JPWO2020204149A1 - - Google Patents

Info

Publication number
JPWO2020204149A1
JPWO2020204149A1 JP2021512313A JP2021512313A JPWO2020204149A1 JP WO2020204149 A1 JPWO2020204149 A1 JP WO2020204149A1 JP 2021512313 A JP2021512313 A JP 2021512313A JP 2021512313 A JP2021512313 A JP 2021512313A JP WO2020204149 A1 JPWO2020204149 A1 JP WO2020204149A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021512313A
Other versions
JP7533896B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020204149A1 publication Critical patent/JPWO2020204149A1/ja
Application granted granted Critical
Publication of JP7533896B2 publication Critical patent/JP7533896B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2021512313A 2019-03-29 2020-03-27 スクリーニング方法および毒性評価法 Active JP7533896B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019066625 2019-03-29
JP2019066625 2019-03-29
PCT/JP2020/015255 WO2020204149A1 (ja) 2019-03-29 2020-03-27 スクリーニング方法および毒性評価法

Publications (2)

Publication Number Publication Date
JPWO2020204149A1 true JPWO2020204149A1 (ja) 2020-10-08
JP7533896B2 JP7533896B2 (ja) 2024-08-14

Family

ID=72668513

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021512313A Active JP7533896B2 (ja) 2019-03-29 2020-03-27 スクリーニング方法および毒性評価法

Country Status (6)

Country Link
US (1) US20220252575A1 (ja)
EP (1) EP3950953A4 (ja)
JP (1) JP7533896B2 (ja)
KR (1) KR20210144793A (ja)
CN (1) CN113748213A (ja)
WO (1) WO2020204149A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4332215A1 (en) * 2021-04-28 2024-03-06 National University Corporation Tokyo Medical and Dental University Method for producing cells

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011514329A (ja) * 2008-02-15 2011-05-06 タフツ ユニバーシティー マウス網膜上への細胞膜傷害複合体（ｍａｃ）生成のヒト化モデル、並びに、黄斑変性の処置のための組成物とキットと方法
JP2015503909A (ja) * 2011-12-21 2015-02-05 ノバルティス アーゲー Ｐ因子を標的とする抗体のための組成物および方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US20020103360A1 (en) 1998-09-01 2002-08-01 Yang Pan Novel protein related to melanoma-inhibiting protein and uses thereof
DE502004001104D1 (de) 2004-04-10 2006-09-14 Henkel Kgaa Lockenwickler
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
EP3418297B1 (en) 2005-12-13 2023-04-05 Kyoto University Nuclear reprogramming factor
US7661738B2 (en) 2006-11-28 2010-02-16 Veritainer Corporation Radiation detection unit for mounting a radiation sensor to a container crane
EP2145000A4 (en) 2007-04-07 2010-05-05 Whitehead Biomedical Inst REPROGRAMMING SOMATIC CELLS
EP2164951A2 (en) 2007-05-30 2010-03-24 The General Hospital Corporation Methods of generating pluripotent cells from somatic cells
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
WO2012016162A2 (en) * 2010-07-29 2012-02-02 Tufts University Compositions, methods and kits for modeling, diagnosing, and treating complement disorders
JP6083877B2 (ja) 2011-11-18 2017-02-22 国立大学法人京都大学 多能性幹細胞から骨格筋細胞への分化誘導方法
WO2013075222A1 (en) 2011-11-21 2013-05-30 University Health Network Populations of hematopoietic progenitors and methods of enriching stem cells therefor
KR102215373B1 (ko) 2013-08-06 2021-02-10 다케다 야쿠힌 고교 가부시키가이샤 도파민 뉴런의 제조 방법
JP6518878B2 (ja) 2013-10-09 2019-05-29 株式会社ヘリオス 網膜色素上皮細胞の製造方法
JP6736003B2 (ja) 2014-11-13 2020-08-05 国立大学法人京都大学 多能性幹細胞からｔ細胞への誘導方法
EP3476934A4 (en) 2016-06-23 2020-02-26 Kyoto University METHOD FOR PRODUCING CD4 / CD8 POSITIVE DUAL T CELLS
JP7032634B2 (ja) 2017-09-29 2022-03-09 日亜化学工業株式会社 光学エンジン及びプロジェクタ

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011514329A (ja) * 2008-02-15 2011-05-06 タフツ ユニバーシティー マウス網膜上への細胞膜傷害複合体（ｍａｃ）生成のヒト化モデル、並びに、黄斑変性の処置のための組成物とキットと方法
JP2015503909A (ja) * 2011-12-21 2015-02-05 ノバルティス アーゲー Ｐ因子を標的とする抗体のための組成物および方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HALLAM, D. ET AL.: "An Induced Pluripotent Stem Cell Patient Specific Model of Complement Factor H (Y402H) Polymorphism", STEM CELLS, vol. 35, JPN6020021515, 15 September 2017 (2017-09-15), pages 2305 - 2320, ISSN: 0005186237 *

Also Published As

Publication number Publication date
WO2020204149A1 (ja) 2020-10-08
EP3950953A1 (en) 2022-02-09
US20220252575A1 (en) 2022-08-11
KR20210144793A (ko) 2021-11-30
EP3950953A4 (en) 2023-04-19
CN113748213A (zh) 2021-12-03
JP7533896B2 (ja) 2024-08-14

Similar Documents

Publication Publication Date Title
BR112019017762A2 (ja)
BR112021018450A2 (ja)
BR112019016141A2 (ja)
BR112021017939A2 (ja)
BR112021017892A2 (ja)
AU2020104490A5 (ja)
BR112019016142A2 (ja)
BR112019016138A2 (ja)
BR112021018168A2 (ja)
BR112021008711A2 (ja)
BR112021018452A2 (ja)
BR112021018102A2 (ja)
BR112021018584A2 (ja)
BR112021015080A2 (ja)
BR112021012348A2 (ja)
BR112021018250A2 (ja)
BR112021018093A2 (ja)
BR112021018084A2 (ja)
BR112021013944A2 (ja)
BR112021013128A2 (ja)
BR112021018484A2 (ja)
JPWO2020204149A1 (ja)
BR112021017949A2 (ja)
BR112021017983A2 (ja)
BR112021016996A2 (ja)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20210907

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221216

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231031

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231221

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240227

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240416

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240716

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240724

R150 Certificate of patent or registration of utility model

Ref document number: 7533896

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150